Statement Of Cash Flows

ZERIA PHARMCEUTICAL CO., LTD. - Filing #7247022

Concept	As at 2025-03-31	2024-04-01 to 2025-03-31	2023-04-01 to 2024-03-31	As at 2024-03-31	As at 2023-03-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal	—	13,791,609,000 JPY	13,107,561,000 JPY	—	—
Interest and dividends received	—	623,494,000 JPY	438,760,000 JPY	—	—
Income taxes paid	—	-1,001,049,000 JPY	-915,993,000 JPY	—	—
Interest paid	—	-492,007,000 JPY	-446,719,000 JPY	—	—
Net cash provided by (used in) operating activities	—	12,922,046,000 JPY	12,183,609,000 JPY	—	—
Cash flows from operating activities
Cash flows from operating activities
Cash flows from facilities maintenance and investing activities
Purchase of property, plant and equipment	—	-1,429,102,000 JPY	-2,900,688,000 JPY	—	—
Purchase of investment securities	—	JPY	-2,313,000 JPY	—	—
Proceeds from sale of investment securities	—	JPY	2,018,805,000 JPY	—	—
Cash flows from investing activities
Net cash provided by (used in) investing activities	—	-1,050,885,000 JPY	-3,952,373,000 JPY	—	—
Cash flows from financing activities
Purchase of treasury shares	—	-662,000 JPY	-824,000 JPY	—	—
Dividends paid	—	-1,976,755,000 JPY	-1,935,396,000 JPY	—	—
Proceeds from long-term borrowings	—	3,273,000,000 JPY	500,000,000 JPY	—	—
Repayments of long-term borrowings	—	-8,515,015,000 JPY	-5,778,110,000 JPY	—	—
Net cash provided by (used in) financing activities	—	-7,756,699,000 JPY	-8,124,090,000 JPY	—	—
Effect of exchange rate change on cash and cash equivalents	—	749,071,000 JPY	2,402,921,000 JPY	—	—
Net increase (decrease) in cash and cash equivalents	—	4,863,532,000 JPY	2,510,065,000 JPY	—	—
Cash and cash equivalents	23,467,676,000 JPY	—	—	18,604,144,000 JPY	16,094,078,000 JPY